Syncom Formulations
17.11
-0.26(-1.50%)
Market Cap₹1,632.80 Cr
PE Ratio28.28
IndustryHealthcare
Company Performance:
1D-1.50%
1M-8.89%
6M+2.52%
1Y+5.36%
5Y+111.23%
View Company Insightsright
Latest news about Syncom Formulations
Syncom Formulations Announces Dual Leadership Resignations: CFO and Whole-time Director Step Down 3 hours ago Today
Syncom Formulations (India) Limited reported the resignations of two senior executives. Shri Ankit Kedarmal Bankda stepped down as Chief Financial Officer, and Smt. Rinki Ankit Banka resigned as Director and Whole-time Director, both effective August 8, 2025. The company disclosed this information on August 18, 2025, citing internal processing and settlement formalities as reasons for the delayed announcement. The resignations were reported in compliance with SEBI regulations.
Syncom Formulations Reports Strong Q1 Growth with Revenue Up 34% and Net Profit Doubling 10 days ago
Syncom Formulations Reports Impressive Q4 Results with Soaring Profits and Revenue May 20, 2025
Syncom Formulations Reports Impressive Q4 Financial Results with Substantial Growth May 19, 2025